Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$3.75 USD
-0.34 (-8.31%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.76 +0.01 (0.27%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
APDN 3.75 -0.34(-8.31%)
Will APDN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for APDN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APDN
Allegion (ALLE) Q1 Earnings Surpass Estimates
Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year?
APDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates
ADT (ADT) Q2 Earnings and Revenues Miss Estimates
Proto Labs (PRLB) Q2 Earnings and Revenues Top Estimates
Other News for APDN
Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more
Applied DNA Sciences Unveils New Investor Engagement Material
Applied Dna Sciences, OptimizeRx, SCWorx among healthcare movers
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
Applied DNA Sciences trading halted, news pending